Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
191,326,157
-
Shares change
-
+45,718,730
-
Total reported value, excl. options
-
$438,152,499
-
Value change
-
+$104,558,326
-
Put/Call ratio
-
1002%
-
Number of buys
-
79
-
Number of sells
-
-28
-
Price
-
$2.29
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2023
134 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2023.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 191,326,157 shares
of 363,214,619 outstanding shares and own 53% of the company stock.
Largest 10 shareholders include Artal Group S.A. (117,553,284 shares), BVF INC/IL (19,995,332 shares), FMR LLC (8,511,068 shares), VANGUARD GROUP INC (6,456,952 shares), BlackRock Inc. (6,379,186 shares), JPMORGAN CHASE & CO (2,931,169 shares), MILLENNIUM MANAGEMENT LLC (2,634,173 shares), NEA Management Company, LLC (2,382,286 shares), PINNACLE ASSOCIATES LTD (1,993,627 shares), and Octagon Capital Advisors LP (1,923,076 shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.